Dale Pfost

Dale Pfost is a highly accomplished biotech industry veteran who was recently appointed as Co-Chairman of the Board at AxoSim, a company specializing in 3D organoid neurodiscovery platforms.1

Professional Background

Dr. Pfost brings extensive experience to his role at AxoSim:

• He has served as CEO of six biotechnology companies, with three of them becoming publicly traded and reaching valuations exceeding $2 billion.1
• He was previously a General Partner at Advent Life Sciences, a venture capital firm.1
• Dr. Pfost co-founded and acted as CEO of MicroBiome Therapeutics.1

Education and Achievements

• He holds a BS degree from the University of California, Santa Barbara.1
• Dr. Pfost earned a PhD in physics from Brown University.1
• He is credited as a co-author on 10 scientific papers and an inventor on 10 patents, showcasing his contributions to scientific research and innovation.1

Role at AxoSim

As Co-Chairman of the Board at AxoSim, Dr. Pfost is expected to leverage his broad expertise in life science tools and venture finance to support the company's growth.1 His appointment, alongside Dr. David Weiner, comes at a time when AxoSim is expanding its leadership in human organoid technologies aimed at making neurological R&D faster, more efficient, and more successful.1

Dr. Pfost's experience in building successful biotechnology companies across therapeutics, diagnostics, and life science tools positions him well to contribute to AxoSim's strategic direction and growth initiatives.1